Over the years, several molecular pathways known to control MMΦ-mediated phagocytosis, for example, CD36,4 LRP1,57 AXL/MERTK,58 CD4759 were demonstrated to help in hematoma clearance and improved recovery in animal models of ICH. The gene discussed is MERTK; the disease is hematoma.